United States (Change Country)Masitinib (AB1010) Chemical Structure
Masitinib (AB1010) is a tyrosine kinase, c-Kit, PDGFR, FGFR3, the FAK pathway inhibitor with IC50 of 150 ± 80, 200 ± 40 nM for KIT tyrosine phosphorylation and the recombinant human wild-type KIT. It can enhance the antiproliferative effects of gemcitabine (GEM) in human pancreatic cancer cells. It potently inhibited human and murine KIT with activating mutations in the juxtamembrane domain. In vivo, masitinib (AB1010) blocked tumour growth in mice with subcutaneous grafts of Ba/F3 cells expressing a juxtamembrane KIT mutant. [1][2][3]
[1] PLoS ONE September 2009;4:e7258
[2] Allergy 2009;64: 1194–1201
[3] Stem Cells 2005;23:16–43
| Molecular Weight (WM): | 498.64 |
|---|---|
| Formula: | C28H30N6OS |
| Solubility(R.T.:25°C): | DMSO 100mg/mL |
| Water <1mg/mL | |
| Ethanol 4mg/mL |
A collection of 715 inhibitors
A collection of 271 kinase inhibitors
A collection of 785 FDA approved drugs
A collection of 144 natural products
A collection of 84 chemotherapeutic agents
A collection of 1463 bioactive compounds
A collection of 117 tyrosine kinase inhibitors
Francois VaillantThe Walter and Eliza Hall Institute of Medical Research Australia
Keywords:buy Masitinib (AB1010) | Masitinib (AB1010) supplier | purchase Masitinib (AB1010) | Masitinib (AB1010) cost | Masitinib (AB1010) manufacturer | order Masitinib (AB1010) | Masitinib (AB1010) distributor